José M Matés

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 9

Top Venues

Cancers

Antioxidants (Basel, Switzerland)

Nature medicine

Journal of biomedical science

University of Málaga (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Málaga Oct 01 1988 - May 04 1992

Spain

PHD :: Molecular Biology and Biochemistry

Publications

Juan De Los Santos-Jiménez, José A Campos-Sandoval, Francisco J Alonso, Javier Márquez, José M Matés
GLS and GLS2 Glutaminase Isoenzymes in the Antioxidant System of Cancer Cells. Antioxidants (Basel, Switzerland) 13 (6) (2024)
Juan De Los Santos-Jiménez, José A Campos-Sandoval, Francisco J Alonso, Javier Márquez, José M Matés
GLS and GLS2 Glutaminase Isoenzymes in the Antioxidant System of Cancer Cells. Antioxidants (Basel, Switzerland) 13 (6) (2024)
Juan De Los Santos-Jiménez, Tracy Rosales, Bookyung Ko, José A Campos-Sandoval, Francisco J Alonso, Javier Márquez, Ralph J DeBerardinis, José M Matés
Metabolic Adjustments following Glutaminase Inhibition by CB-839 in Glioblastoma Cell Lines. Cancers 15 (2) (2023)
Juan De Los Santos-Jiménez, Tracy Rosales, Bookyung Ko, José A Campos-Sandoval, Francisco J Alonso, Javier Márquez, Ralph J DeBerardinis, José M Matés
Metabolic Adjustments following Glutaminase Inhibition by CB-839 in Glioblastoma Cell Lines. Cancers 15 (2) (2023)
Juan de Los Santos-Jiménez, José A Campos-Sandoval, Clara Márquez-Torres, Nieves Urbano-Polo, David Brøndegaard, Mercedes Martín-Rufián, Carolina Lobo, Ana Peñalver, María C Gómez-García, Janet Martín-Campos, Carolina Cardona, Laura Castilla, Felipe da Costa Souza, Tzuling Cheng, Juan A Segura, Francisco J Alonso, Rui Curi, Alison Colquhoun, Ralph J DeBerardinis, Javier Márquez, José M Matés
Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells. Journal of biomedical science 28 (1) (2021)
Javier Márquez, José M Matés
Tumor Metabolome: Therapeutic Opportunities Targeting Cancer Metabolic Reprogramming. Cancers 13 (2) (2021)
José M Matés, José A Campos-Sandoval, Juan de Los Santos-Jiménez, Javier Márquez
Glutaminases regulate glutathione and oxidative stress in cancer. Archives of toxicology 94 (8) (2020)
Esmeralda Ramirez-Peña, James Arnold, Vinita Shivakumar, Robiya Joseph, Geraldine Vidhya Vijay, Petra den Hollander, Neeraja Bhangre, Paul Allegakoen, Rishika Prasad, Zachary Conley, José M Matés, Javier Márquez, Jeffrey T Chang, Suhas Vasaikar, Rama Soundararajan, Arun Sreekumar, Sendurai A Mani
The Epithelial to Mesenchymal Transition Promotes Glutamine Independence by Suppressing GLS2 Expression. Cancers 11 (10) (2019)
Daniel Herranz, Alberto Ambesi-Impiombato, Jessica Sudderth, Marta Sánchez-Martín, Laura Belver, Valeria Tosello, Luyao Xu, Agnieszka A Wendorff, Mireia Castillo, J Erika Haydu, Javier Márquez, José M Matés, Andrew L Kung, Stephen Rayport, Carlos Cordon-Cardo, Ralph J DeBerardinis, Adolfo A Ferrando
Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia. Nature medicine 21 (10) (2015)

José M Matés.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

José M Matés